5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Type (By Diagnostic and Monitoring Devices, Therapeutic Devices and Disposables)
The market for respiratory devices has been increasing in Sweden primarily due to increasing prevalence of respiratory disorders, such as COPD, TB, Asthma, and Sleep Apnea. The prevalence of chronic obstructive pulmonary disease (COPD) in the adult population in Sweden is approximately 10%, according to Josefin Sundh et al., published in European Clinical Respiratory Journal 2017. This has been the primary reason for the growth in demand for respiratory devices in Sweden.
Owing to the rapid advancements, the population has been benefited with the new technologies which are more effective. This has propelled the growth of the market even further. However, the high cost of devices and instruments has been restraining the market growth.
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation, by forcing oxygen into the lungs of a person who has undergone asphyxia.
Report scope can be customized per your requirements. Click here.
As per the report by Eivind Borna et al., published in European Journal of Allergy and Clinical Immunology 2019, the prevalence of reported ever asthma, physician‐diagnosed asthma, use of asthma medication, and current asthma has increased significantly from 9.6% to 11%, 8.3% to 10%, 8.6% to 9.8%, and 8.1% to 9.1%, respectively, between 2008 and 2016. There are also increase in the prevalence of respiratory symptoms during the same period.
Inhalers are very common among asthma patients as a delivery method. Asthma inhalers are hand-held, portable devices that deliver medication to your lungs. A variety of asthma inhalers are available to help control the asthma symptoms. Hence as the prevalence of asthma increases in Sweden, the demand for inhalers is also expected to increase as well. This is expected to help the market growth in the region.
To understand key trends, Download Sample Report
Sweden is a developed country with well-structured healthcare system in the country. As a result, many global players in the respiratory devices market are present in the country. Moreover, some domestic players like Breas Medical (now a subsidiary of Fosun Pharmaceutical) have also been competing in the Sweden market. These factors have made the region very competitive.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
4.2.2 Technological Advancements and Increasing Applications in Homecare Setting
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices
18.104.22.168 Sleep Test Devices
22.214.171.124 Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices
126.96.36.199 CPAP Devices
188.8.131.52 Other Therapeutic Devices
5.1.3 By Disposables
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Dragerwerk AG
6.1.2 Fisher & Paykel Healthcare Ltd
6.1.3 Fosun Pharmaceutical (Breas Medical AB)
6.1.4 GE Healthcare
6.1.5 GlaxoSmithKline PLC
6.1.6 Invacare Corporation
6.1.7 Koninklijke Philips NV
6.1.8 Medtronic PLC
6.1.9 Smiths Medical Inc
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments